SC 13D/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Published on April 19, 2001
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 1)
Omega Healthcare Investors, Inc.
------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.10 per share
------------------------------------------------------------------------
(Title of Class of Securities)
681936100
------------------------------------------------------
(CUSIP Number)
Thomas W. Bark, Esq.
Jones, Day, Reavis & Pogue
599 Lexington Avenue
New York, New York 10022
(212) 326-7815
------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
March 30, 2001
---------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the reporting person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box /_/.
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.
CUSIP NO. 681936100 13D Page 2 of 14 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Explorer Holdings, L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) /_/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) /_/
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY --------------------------------------------------------------
EACH REPORTING 8 SHARED VOTING POWER
PERSON WITH
16,774,720**
--------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
16,774,720**
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,774,720**
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES/_/*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
45.6%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**This amount includes (i) 1,000,000 shares of Series C Convertible Preferred
stock previously reported by the Reporting Person, which are convertible into
16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C
Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001,
which are convertible into 774,720 shares of Omega's common stock.
CUSIP NO. 681936100 13D Page 3 of 14 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Explorer Holdings GenPar, LLC
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) /_/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) /_/
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY --------------------------------------------------------------
EACH REPORTING 8 SHARED VOTING POWER
PERSON WITH
16,774,720**
--------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
16,774,720**
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,774,720**
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES/_/*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
45.6%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
00
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**This amount includes (i) 1,000,000 shares of Series C Convertible Preferred
stock previously reported by the Reporting Person, which are convertible into
16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C
Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001,
which are convertible into 774,720 shares of Omega's common stock.
CUSIP NO. 681936100 13D Page 4 of 14 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Hampstead Investment Partners III, L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) /_/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) /_/
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY -------------------------------------------------------------
EACH REPORTING 8 SHARED VOTING POWER
PERSON WITH
16,774,720**
-------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
-------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
16,774,720**
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,774,720**
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES/_/*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
45.6%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**This amount includes (i) 1,000,000 shares of Series C Convertible Preferred
stock previously reported by the Reporting Person, which are convertible into
16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C
Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001,
which are convertible into 774,720 shares of Omega's common stock.
CUSIP NO. 681936100 13D Page 5 of 14 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Donald J. McNamara
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) /_/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) /_/
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY -------------------------------------------------------------
EACH REPORTING 8 SHARED VOTING POWER
PERSON WITH
16,774,720**
-------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
-------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
16,774,720**
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,774,720**
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES/_/*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
45.6%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**This amount includes (i) 1,000,000 shares of Series C Convertible Preferred
stock previously reported by the Reporting Person, which are convertible into
16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C
Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001,
which are convertible into 774,720 shares of Omega's common stock.
CUSIP NO. 681936100 13D Page 6 of 14 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
Daniel A. Decker
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/
(b) /_/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e) /_/
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES
BENEFICIALLY None
OWNED BY -------------------------------------------------------------
EACH REPORTING 8 SHARED VOTING POWER
PERSON WITH
16,774,720**
-------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
None
-------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
16,774,720**
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,774,720**
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES/_/*
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
45.6%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
**This amount includes (i) 1,000,000 shares of Series C Convertible Preferred
stock previously reported by the Reporting Person, which are convertible into
16,000,000 shares of Omega's common stock and (ii) 48,420 shares of Series C
Convertible Preferred Stock acquired by the Reporting Person on March 30, 2001,
which are convertible into 774,720 shares of Omega's common stock.
This amendment amends and supplements the information set forth in the
Statement on Schedule 13D filed on May 25, 2000 by (i) Explorer Holdings, L.P.,
a Delaware limited partnership ("HOLDINGS"), (ii) Explorer Holdings GenPar, LLC,
a Delaware limited liability company and the general partner of Holdings
("GENERAL PARTNER"), (iii) Hampstead Investment Partners III, L.P., a Delaware
limited partnership ("PARENT"), (iv) Donald J. McNamara, and (v) Daniel A.
Decker, relating to securities of Omega Healthcare Investors, Inc., a Maryland
corporation (the "COMPANY"). Holdings, General Partner, Parent and Messrs.
McNamara and Decker are collectively referred to herein as Reporting Persons.
ITEM 1. SECURITY AND ISSUER.
This amendment relates to the Series C Convertible Preferred Stock, par
value $1.00 per share (the "PREFERRED STOCK"), of the Company.
ITEM 5. INTEREST IN SECURITY OF THE ISSUER.
Item 5 is hereby amended and supplemented by adding thereto the following:
(a) Each of the Reporting Persons beneficially owns 16,774,720 Shares,
consisting of (i) 1,000,000 shares of Preferred Stock previously reported, which
are convertible into 16,000,000 shares of common stock of the Company and (ii)
48,420 shares of Preferred Stock acquired by the Reporting Persons on March 30,
2001, which are convertible into 774,720 shares of common stock of the Company.
(c) Holdings received 46,666 shares of Preferred Stock on March 30, 2001
as "paid-in-kind" dividends on the Preferred Stock for the period from August 1,
2000 to October 31, 2000. Holdings received 1,754 shares of Preferred Stock on
March 30, 2001, which are convertible into 28,064 shares of common stock of the
Company, in exchange for the delayed payment of the dividend described above.
ITEM 7. MATERIALS TO BE FILED AS EXHIBITS.
Exhibit 1: Powers of Attorney for the Reporting Persons (filed herewith).
Page 7 of 14 Pages
SIGNATURES
After reasonable inquiry and to the best of its knowledge and belief, each
of the undersigned certifies that the information set forth in this statement is
true, complete and correct, and agrees that this Statement may be filed
collectively on behalf of each of the undersigned by Explorer Holdings, L.P.,
Explorer Holdings GenPar, LLC, Hampstead Investment Partners III, L.P., Donald
J. McNamara and Daniel A. Decker.
Date: April 10, 2001 EXPLORER HOLDINGS, L.P.
By: Explorer Holdings GenPar, LLC,
its General Partner
By: /s/ Daniel A. Decker
---------------------------
Daniel A. Decker
Managing Member
EXPLORER HOLDINGS GENPAR, LLC
By: /s/ William T. Cavanaugh, Jr.
---------------------------------
William T. Cavanaugh, Jr.
Authorized Officer
HAMPSTEAD INVESTMENT PARTNERS III, L.P.
By: Hampstead Investment Partners III
GenPar, L.P., its General Partner
By: Hampstead GenPar III, LLC,
its General Partner
By: /s/ William T. Cavanaugh, Jr.
-------------------------------
William T. Cavanaugh, Jr.
Authorized Officer
/s/ Donald J. McNamara
-----------------------------------
Donald J. McNamara
/s/ Daniel A. Decker
-----------------------------------
Daniel A. Decker
Page 8 of 14 Pages
EXHIBIT INDEX
Exhibit 1: Powers of Attorney for the Reporting Persons (filed herewith).
Page 9 of 14 Pages
POWER OF ATTORNEY
Statements on Schedule 13D
Explorer Holdings, L.P. (the "Company") hereby constitutes and appoints
William T. Cavanaugh, Jr., Daniel A. Decker and Donald J. McNamara, and each of
them, as the Company's true and lawful attorney-in-fact and agent, with full
power of substitution and resubstitution, to sign on the Company's behalf any or
all Statements on Schedule 13D, and any or all amendments thereto, relating to
the capital stock of Omega Healthcare Investors, Inc. and to file the same, with
all exhibits thereto, with the Securities and Exchange Commission, granting unto
said attorneys-in fact or agents and each of them, full power and authority to
do and perform each and every act and thing requisite and necessary to be done
in and about the promises, hereby ratifying and confirming all that said
attorneys-in-fact or agents, or any of them or their substitutes, may lawfully
do or cause to be done by virtue hereof.
EXPLORER HOLDINGS, L.P.
By: Explorer Holdings GenPar, LLC,
Its General Partner
By: /s/ Daniel A. Decker
--------------------------------
Daniel A. Decker
Managing Member
Page 10 of 14 Pages
POWER OF ATTORNEY
Statements on Schedule 13D
Explorer Holdings GenPar, LLC (the "Company") hereby constitutes and
appoints William T. Cavanaugh, Jr., Daniel A. Decker and Donald J. McNamara, and
each of them, as the Company's true and lawful attorney-in-fact and agent, with
full power of substitution and resubstitution, to sign on the Company's behalf
any or all Statements on Schedule 13D, and any or all amendments thereto,
relating to the capital stock of Omega Healthcare Investors, Inc. and to file
the same, with all exhibits thereto, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact or agents and each of them,
full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the promises, hereby ratifying
and confirming all that said attorneys-in-fact or agents, or any of them or
their substitutes, may lawfully do or cause to be done by virtue hereof.
EXPLORER HOLDINGS GENPAR, LLC
By: /s/ William T. Cavanaugh, Jr.
---------------------------------
William T. Cavanaugh, Jr.
Authorized Officer
Page 11 of 14 Pages
POWER OF ATTORNEY
Statements on Schedule 13D
Hampstead Investment Partners III, L.P. (the "Company") hereby constitutes
and appoints William T. Cavanaugh, Jr., Daniel A. Decker and Donald J. McNamara,
and each of them, as the Company's true and lawful attorney-in-fact and agent,
with full power of substitution and resubstitution, to sign on the Company's
behalf any or all Statements on Schedule 13D, and any or all amendments thereto,
relating to the capital stock of Omega Healthcare Investors, Inc. and to file
the same, with all exhibits thereto, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact or agents and each of them,
full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the promises, hereby ratifying
and confirming all that said attorneys-in-fact or agents, or any of them or
their substitutes, may lawfully do or cause to be done by virtue hereof.
HAMPSTEAD INVESTMENT PARTNERS III, L.P.
By: Hampstead Investment Partners III
GenPar, L.P., Its General Partner
By: Hampstead GenPar III, LLC,
its General Partner
By: /s/ William T. Cavanaugh, Jr.
-------------------------------------
William T. Cavanaugh, Jr.
Authorized Officer
Page 12 of 14 Pages
POWER OF ATTORNEY
Statements on Schedule 13D
The undersigned hereby constitutes and appoints William T. Cavanaugh, Jr.
and Daniel A. Decker, and each of them, as the undersigned's true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution,
to sign on the undersigned's behalf any or all Statements on Schedule 13D, and
any or all amendments thereto, relating to the capital stock of Omega Healthcare
Investors, Inc., and to file the same, with all exhibits thereto, with the
Securities and Exchange Commission, granting unto said attorneys-in-fact or
agents and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done in and about the
promises, hereby ratifying and confirming all that said attorneys-in-fact or
agents, or any of them or their substitutes, may lawfully do or cause to be done
by virtue hereof.
/s/ Donald J. McNamara
--------------------------
Donald J. McNamara
Page 13 of 14 Pages
POWER OF ATTORNEY
Statements on Schedule 13D
The undersigned hereby constitutes and appoints William T. Cavanaugh, Jr.
and Donald J. McNamara, and each of them, as the undersigned's true and lawful
attorney-in-fact and agent, with full power of substitution and resubstitution,
to sign on the undersigned's behalf any or all Statements on Schedule 13D, and
any or all amendments thereto, relating to the capital stock of Omega Healthcare
Investors, Inc., and to file the same, with all exhibits thereto, with the
Securities and Exchange Commission, granting unto said attorneys-in-fact or
agents and each of them, full power and authority to do and perform each and
every act and thing requisite and necessary to be done in and about the
promises, hereby ratifying and confirming all that said attorneys-in-fact or
agents, or any of them or their substitutes, may lawfully do or cause to be done
by virtue hereof.
/s/ Daniel A. Decker
--------------------------
Daniel A. Decker
Page 14 of 14 Pages